Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03240081 · ClinicalTrials.gov registry record · Phase 4
Treating Postmenopausal Dyspareunia Where it Hurts
A Phase 4 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT03240081 is a Phase 4 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 50 participants.
The verdict
NCT03240081, a Phase 4 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effectiveness of two low doses of estrogen cream applied to a new location for the treatment of moderate or severe pain during sexual intercourse in postmenopausal women.
Interventions
- DRUG 50mcg estradiol cream
- DRUG 100mcg estradiol cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-06-20 |
| Est. Completion | 2019-11-21 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03240081
The ClinicalTrials.gov registry entry for NCT03240081 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 50mcg estradiol cream is the first listed.
NCT03240081 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03240081 about?
NCT03240081 is a clinical study titled "Treating Postmenopausal Dyspareunia Where it Hurts". The purpose of this study is to compare the effectiveness of two low doses of estrogen cream applied to a new location for the treatment of moderate or severe pain during sexual intercourse in postmenopausal women.
What is the current status of trial NCT03240081?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2017-06-20. Estimated completion is 2019-11-21.
What interventions are being tested in trial NCT03240081?
The interventions under investigation include: 50mcg estradiol cream (DRUG), 100mcg estradiol cream (DRUG).
Who is sponsoring clinical trial NCT03240081?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.